Correction: Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells.
作者信息
Lu Yu, Zhang Xiaobo
机构信息
College of Life Sciences, Laboratory for Marine Biology and Biotechnology of Pilot National Laboratory for Marine Science and Technology (Qingdao) and Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai), Zhejiang University, Hangzhou, 310058, People's Republic of China.
出版信息
Stem Cell Res Ther. 2024 Oct 10;15(1):358. doi: 10.1186/s13287-024-03984-x.
Abstract
摘要
相似文献
1
Correction: Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells.更正：放化疗诱导的DNA修复促进胃癌干细胞的生物发生。
Stem Cell Res Ther. 2024 Oct 10;15(1):358. doi: 10.1186/s13287-024-03984-x.
2
Radiochemotherapy-induced DNA repair promotes the biogenesis of gastric cancer stem cells.放化疗诱导的 DNA 修复促进胃癌干细胞的发生。
Stem Cell Res Ther. 2022 Sep 24;13(1):481. doi: 10.1186/s13287-022-03165-8.
3
Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer.局部晚期胃食管交界癌和不可切除的局部晚期胃癌的术前放化疗治疗
Radiol Oncol. 2015 Mar 25;49(2):163-72. doi: 10.2478/raon-2014-0027. eCollection 2015 Jun.
4
Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.放化疗诱导产生的癌症干细胞及其治疗意义。
Oncotarget. 2017 Mar 7;8(10):17301-17312. doi: 10.18632/oncotarget.14230.
5
The Effect of the Prognostic Nutritional Index on the Toxic Side Effects of Radiochemotherapy and Prognosis After Radical Surgery for Gastric Cancer.预后营养指数对胃癌根治术后放化疗毒性副作用及预后的影响
Cancer Manag Res. 2021 Apr 16;13:3385-3392. doi: 10.2147/CMAR.S301140. eCollection 2021.
6
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.METTL3 通过促进 PARP1 mRNA 稳定性促进胃癌 CD133+ 干细胞对奥沙利铂的耐药性。
Cell Mol Life Sci. 2022 Feb 18;79(3):135. doi: 10.1007/s00018-022-04129-0.
7
Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection.SWOG 指导的分组研究 0116 的更新分析：辅助放化疗与根治性胃癌切除术后观察的 III 期临床试验。
J Clin Oncol. 2012 Jul 1;30(19):2327-33. doi: 10.1200/JCO.2011.36.7136. Epub 2012 May 14.
8
Clinical Efficacy and Adverse Reactions of Bevacizumab plus Radiochemotherapy in the Treatment of Advanced Gastric Cancer.贝伐单抗联合放化疗治疗晚期胃癌的临床疗效及不良反应
J Oncol. 2022 Feb 8;2022:4900037. doi: 10.1155/2022/4900037. eCollection 2022.
9
microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.与局部进展期胃癌患者术前放化疗反应相关的 microRNAs 表达谱。
BMC Cancer. 2018 Oct 29;18(1):1048. doi: 10.1186/s12885-018-4967-4.
10
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group.DNA 修复途径的遗传变异与食管腺癌放化疗反应：东部合作肿瘤学组的回顾性队列研究。
BMC Cancer. 2011 May 17;11:176. doi: 10.1186/1471-2407-11-176.
引用本文的文献
1
Deciphering Radiotherapy Resistance: A Proteomic Perspective.从蛋白质组学角度解析放疗抗性
Proteomes. 2025 Jun 16;13(2):25. doi: 10.3390/proteomes13020025.
Zotero 插件